These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14766899)

  • 1. Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines.
    Grazide S; Terrisse AD; Lerouge S; Laurent G; Jaffrézou JP
    J Biol Chem; 2004 Apr; 279(18):18256-61. PubMed ID: 14766899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
    Shabbits JA; Mayer LD
    Mol Cancer Ther; 2002 Jan; 1(3):205-13. PubMed ID: 12467215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
    Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells.
    di Bartolomeo S; Spinedi A
    Biochem Biophys Res Commun; 2001 Oct; 288(1):269-74. PubMed ID: 11594784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
    Norris-Cervetto E; Callaghan R; Platt FM; Dwek RA; Butters TD
    J Biol Chem; 2004 Sep; 279(39):40412-8. PubMed ID: 15263008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
    Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
    J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells.
    Plo I; Lehne G; Beckstrøm KJ; Maestre N; Bettaïeb A; Laurent G; Lautier D
    Mol Pharmacol; 2002 Aug; 62(2):304-12. PubMed ID: 12130682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
    Bieberich E; Freischütz B; Suzuki M; Yu RK
    J Neurochem; 1999 Mar; 72(3):1040-9. PubMed ID: 10037475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.
    Chen B; Yin L; Cheng J; Ding J; Gao C; Sun Y; Zhao G; Wang J; Bao W; Xia G; Gao F; Wang X
    Hematology; 2011 Jan; 16(1):24-30. PubMed ID: 21269564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis.
    Huang WC; Tsai CC; Chen CL; Chen TY; Chen YP; Lin YS; Lu PJ; Lin CM; Wang SH; Tsao CW; Wang CY; Cheng YL; Hsieh CY; Tseng PC; Lin CF
    FASEB J; 2011 Oct; 25(10):3661-73. PubMed ID: 21705667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244.
    Wang T; Wei J; Wang N; Ma JL; Hui PP
    Biochem Biophys Res Commun; 2015 Jan; 456(3):821-6. PubMed ID: 25498501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase.
    Nicholson KM; Quinn DM; Kellett GL; Warr JR
    Br J Cancer; 1999 Oct; 81(3):423-30. PubMed ID: 10507766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of the salvage pathway to N-hexanoylsphingosine metabolic downregulation in human neurotumor cells: implications for apoptosis.
    Spinedi A
    Drug Metab Lett; 2012 Mar; 6(1):60-6. PubMed ID: 22372555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of glucosylceramide synthase by synthase inhibitors and ceramide.
    Abe A; Radin NS; Shayman JA
    Biochim Biophys Acta; 1996 Feb; 1299(3):333-41. PubMed ID: 8597588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D,L-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (DL-PDMP) increases endoplasmic reticulum stress, autophagy and apoptosis accompanying ceramide accumulation via ceramide synthase 5 protein expression in A549 cells.
    Yamane M; Miyazawa K; Moriya S; Abe A; Yamane S
    Biochimie; 2011 Sep; 93(9):1446-59. PubMed ID: 21571032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation.
    Bezombes C; de Thonel A; Apostolou A; Louat T; Jaffrézou JP; Laurent G; Quillet-Mary A
    Mol Pharmacol; 2002 Dec; 62(6):1446-55. PubMed ID: 12435813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.
    Usuki S; Hamanoue M; Kohsaka S; Inokuchi J
    J Neurochem; 1996 Nov; 67(5):1821-30. PubMed ID: 8863486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells.
    Allouche M; Bettaieb A; Vindis C; Rousse A; Grignon C; Laurent G
    Oncogene; 1997 Apr; 14(15):1837-45. PubMed ID: 9150390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
    Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
    Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved inhibitors of glucosylceramide synthase.
    Lee L; Abe A; Shayman JA
    J Biol Chem; 1999 May; 274(21):14662-9. PubMed ID: 10329660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.